POLG1 mutations associated with progressive encephalopathy in childhood
Gittan Kollberg1, Ali-Reza Moslemi, Niklas Darin
1Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sweden.
Journal of Neuropathology and Experimental Neurology
|August 10, 2006
Summary
New POLG1 mutations cause progressive encephalopathy and Alpers-Huttenlocher syndrome in children. These genetic defects in mitochondrial DNA polymerase gamma (Pol gamma) lead to severe neurological and organ damage.
Area of Science:
- Genetics
- Neuroscience
- Mitochondrial Biology
Background:
- Alpers-Huttenlocher syndrome is a severe neurodegenerative disorder.
- Mutations in POLG1, encoding mitochondrial DNA polymerase gamma (Pol gamma), are implicated in Alpers-Huttenlocher syndrome.
Observation:
- Seven children from five families presented with progressive encephalopathy.
- Clinical features included psychomotor regression, refractory seizures, stroke-like episodes, hepatopathy, and ataxia.
- Muscle biopsies revealed mitochondrial myopathy with COX deficiency, and mtDNA analysis showed depletion or deletions.
Findings:
- Compound heterozygous missense mutations in POLG1 were identified in all affected children.
- Three novel POLG1 mutations (R574W, R232H, M1163R) were discovered.
- The identified mutations were associated with both mtDNA depletion and deletions, contributing to disease pathogenesis.
Implications:
- These findings expand the spectrum of POLG1 mutations associated with Alpers-Huttenlocher syndrome.
- Understanding these genetic underpinnings is crucial for diagnosing and potentially treating this severe neurodegenerative disease.
- The study highlights the critical role of Pol gamma in maintaining mitochondrial DNA integrity and preventing neurodegeneration.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...